Compare AXGN & NRIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AXGN | NRIM |
|---|---|---|
| Founded | N/A | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 602.6M |
| IPO Year | 2013 | 2002 |
| Metric | AXGN | NRIM |
|---|---|---|
| Price | $42.39 | $26.10 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $42.33 | N/A |
| AVG Volume (30 Days) | ★ 760.1K | 93.6K |
| Earning Date | 04-28-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 2.62% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.29 |
| Revenue | $225,208,000.00 | ★ $255,581,000.00 |
| Revenue This Year | $20.57 | $4.98 |
| Revenue Next Year | $16.68 | $7.40 |
| P/E Ratio | ★ N/A | $20.19 |
| Revenue Growth | 20.21 | ★ 30.43 |
| 52 Week Low | $15.27 | $19.60 |
| 52 Week High | $52.91 | $92.91 |
| Indicator | AXGN | NRIM |
|---|---|---|
| Relative Strength Index (RSI) | 35.61 | 47.97 |
| Support Level | $38.53 | $25.99 |
| Resistance Level | $44.83 | $26.25 |
| Average True Range (ATR) | 2.34 | 0.60 |
| MACD | -0.94 | 0.06 |
| Stochastic Oscillator | 2.75 | 68.66 |
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
Northrim BanCorp Inc is a bank holding company operating through three reportable segments: Community Banking, Home Mortgage Lending, and Specialty Finance. The Community Banking segment, which generates the majority of revenue, provides loan and deposit products to business and consumer customers in its market areas. The Home Mortgage Lending segment focuses on the origination and sale of mortgage loans for one-to-four family residential properties, mortgage loan servicing for certain loans sold, and investment in selected residential mortgage loans. The Specialty Finance segment provides factoring, asset-based lending, and alternative working capital solutions to small and medium-sized enterprises and includes SCF and Northrim Funding Services.